Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B. Pappalardi, Rab K. Prinjha, Kristen Wong et al.|Nature Cancer|2021Cited by 279
Lsd1 as a therapeutic target in Gfi1-activated medulloblastomaCatherine Lee, Robert J. Wechsler‐Reya, Vasilisa A. Rudneva et al.|Nature Communications|2019Cited by 84
Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-<i>trans</i> retinoic acid in acute myeloid leukemia across subtypesKimberly N. Smitheman, Helai P. Mohammad|Haematologica|2018Cited by 63